Best And Worst ETFs Of Q2
Zacks Investment Research | Jul 04, 2017 11:15PM ET
The second quarter of Q2 can be vital to investors for many reasons starting from global policy tightening talks to wavering Trump trade and key elections in an otherwise-improving Europe. Though the broader market was pretty upbeat in the quarter, international markets, especially Europe, clearly beat the U.S. (read: AAXJ added over 6.8%.
Against this backdrop, we highlight the ETF options that topped in the quarter and the ones that flopped.
Gainers
Global X MSCI Greece ETF GREK – Up 26.3%
The Greek economy grew since 2009 .
“Moody's expects to see growth this year and next, after three years of stagnation and a cumulative loss in output of more than 27 percent since the onset of Greece's crisis," the agency said as per the article published on CNBC . As a result, GREK gained 26.3% in the last three months.
ARK Web x.0 ETF ARKW – Up 21.0%
The fund focuses on companies tied to innovation and “Top Sector ETFs of 1H ).
Amplify Online Retail ETF IBUY – Up 19.9%
As of now, online retail sales make up 5 ETFs & Stocks: Silver Lining in Soft May Retail Sales ).
Losers
iPath Bloomberg Natural Gas SubTR ETN GAZ – Down 30.7%
Overall, energy prices underperformed in Q2 on solid U.S. output. Natural gas prices were also victims of the demand-supply imbalance (read: Top & Flop Zones of First Half and Their ETFs ).
Rex VolMaxx Long VIX Weekly Futures Strategy ETF VMAX – Down 30.1%
The fund provides long exposure to the VIX Index by holding a combination of VIX futures contracts that are near expiration. Since volatility touched a multi-year low in Q2, this volatility based fund was badly hurt.
iPath Pure Beta Sugar ETN SGAR – Down 29.5%
Global sugar trading was in dire straits in Q2. “co-produced by sugar mills as sugar cane juice us needed to produce ethanol. With oil price dropping, price of ethanol — which is often used to fuel cars — also declined. This curbed the price of sugar too. Also, “higher duties on sugar imports to top buyer China” hurt sugar prices as per an article published on agrimoney.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.